Utah Medical Products (UTMD) Asset Writedowns and Impairment (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Asset Writedowns and Impairment of -$5000.0 for Q1 2026, up 44.44% year-over-year from -$3461.5 in Q1 2025, and up 82.14% quarter-over-quarter from -$28000.0 in Q4 2025.
Utah Medical Products (UTMD) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Utah Medical Products' Asset Writedowns and Impairment history runs 17 years deep, the most recent figure standing at -$5000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 44.44% year-over-year to -$5000.0; the TTM figure through Mar 2026 stood at $371000.0 (up 7520.0% YoY), while the FY2025 annual figure was $367000.0, up 9275.0% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$5000.0, up from -$28000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $402000.0 in Q3 2025, with the low at -$28000.0 in Q4 2025.
- The 5-year median for Asset Writedowns and Impairment is -$500.0 (2023), against an average of $22187.5.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment soared 300.0% in 2022, then plunged 1500.0% in 2025.
- Utah Medical Products' Asset Writedowns and Impairment stood at $9000.0 in 2022, then slumped by 122.22% to -$2000.0 in 2023, then surged by 200.0% to $2000.0 in 2024, then slumped by 1500.0% to -$28000.0 in 2025, then soared by 82.14% to -$5000.0 in 2026.
- Business Quant data shows UTMD's Asset Writedowns and Impairment at -$5000.0 in Q1 2026, -$28000.0 in Q4 2025, and $402000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,000.00 |
| Jun 30, 2026 | -7,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -28,000.00 |
| Dec 31, 2025 | -28,000.00 |
| Sep 30, 2025 | 402,000.00 |
| Sep 30, 2025 | 402,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |